Literature DB >> 34099134

Awake Proning or Trapping.

George A Mitchell1.   

Abstract

Entities:  

Year:  2021        PMID: 34099134      PMCID: PMC8175941          DOI: 10.1016/j.chest.2020.12.066

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
To the Editor: The article by Raoof et al published in CHEST (November 2020) is well written and informative; however, it may mislead when it comes to proning awake patients with COVID-19 while using noninvasive ventilation or high-flow oxygen. A recent study by Ferrando et al raises concern. In this multicenter, prospective randomized observational trial, the use of awake proning as an adjunctive therapy did not reduce the risk of intubation. Proned patients showed a trend for delay in intubation compared with high-flow nasal oxygen alone; although mortality rates were not affected in this trial, delayed intubation has been shown to increase mortality rates in other trials. Although recognizing that proning improves oxygenation, one must also consider that this intervention potentially may result in delay of needed intubation. Late intubation in ARDS has been shown to increase mortality rates compared with earlier intubation, despite patients who receive early intubation being much sicker. Data from the LUNG SAFE trial demonstrated use of noninvasive ventilation in patients with ARDS is associated with increased ICU mortality rates. After adjustment for comorbidities, patients in that trial who were treated with noninvasive ventilation had a 30% increased risk of dying in the ICU, compared with those who were treated with invasive ventilation. Data from that trial demonstrated that patients who were treated with noninvasive ventilation had higher respiratory rates and tidal volumes compared with those that were intubated. Increased respiratory rate has been found to be a predictor of need for intubation in patients treated with supplemental oxygen, as has been increased tidal volumes in patients treated with noninvasive ventilation. Self-proning patients being treated with noninvasive ventilation or high-flow thus can improve oxygenation, giving a false sense of security resulting in delay of intubation and potentially increased mortality rate. , We should use great caution at this point with self-proning and perhaps limit this intervention to patients who wish not to be intubated until further evidence surfaces.
  4 in total

1.  Timing of Intubation and Clinical Outcomes in Adults With Acute Respiratory Distress Syndrome.

Authors:  Kirsten Neudoerffer Kangelaris; Lorraine B Ware; Chen Yu Wang; David R Janz; Hanjing Zhuo; Michael A Matthay; Carolyn S Calfee
Journal:  Crit Care Med       Date:  2016-01       Impact factor: 7.598

2.  Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome. Insights from the LUNG SAFE Study.

Authors:  Giacomo Bellani; John G Laffey; Tài Pham; Fabiana Madotto; Eddy Fan; Laurent Brochard; Andres Esteban; Luciano Gattinoni; Vesna Bumbasirevic; Lise Piquilloud; Frank van Haren; Anders Larsson; Daniel F McAuley; Philippe R Bauer; Yaseen M Arabi; Marco Ranieri; Massimo Antonelli; Gordon D Rubenfeld; B Taylor Thompson; Hermann Wrigge; Arthur S Slutsky; Antonio Pesenti
Journal:  Am J Respir Crit Care Med       Date:  2017-01-01       Impact factor: 21.405

Review 3.  High-Flow, Noninvasive Ventilation and Awake (Nonintubation) Proning in Patients With Coronavirus Disease 2019 With Respiratory Failure.

Authors:  Suhail Raoof; Stefano Nava; Charles Carpati; Nicholas S Hill
Journal:  Chest       Date:  2020-07-15       Impact factor: 9.410

4.  Awake prone positioning does not reduce the risk of intubation in COVID-19 treated with high-flow nasal oxygen therapy: a multicenter, adjusted cohort study.

Authors:  Carlos Ferrando; Ricard Mellado-Artigas; Alfredo Gea; Egoitz Arruti; César Aldecoa; Ramón Adalia; Fernando Ramasco; Pablo Monedero; Emilio Maseda; Gonzalo Tamayo; María L Hernández-Sanz; Jordi Mercadal; Ascensión Martín-Grande; Robert M Kacmarek; Jesús Villar; Fernando Suárez-Sipmann
Journal:  Crit Care       Date:  2020-10-06       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.